ROTH DAVID (Chief Medical Officer) sold 10.45K shares of SYROS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $51.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/5/2024ACC: 0000950170-24-042289
Officer· Chief Medical Officer
Since Feb 2019
-10.45K
Net shares
Net seller
$51.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.45K
Price / share
$4.95
Trade value
$51.73K
% of position
New position
4/3/2024
10.45K→0.00
Total
Net shares
−10.45K
Net value
-$51.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2024 | S · Sale | −10.45K | $4.95 | $51.73K | New position | 10.45K | 0.00 |
| Total | −10.45K | -$51.73K | ||||||
Derivative Transactions0
No derivative transactions reported